Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

BillionToOne, Inc.

BLLN•NASDAQ
Healthcare
Medical - Diagnostics & Research
$76.38
$-14.05(-15.53%)
U.S. Market is Open • 12:41

BillionToOne, Inc. (BLLN) Stock Overview

Explore BillionToOne, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap3.9B
P/E Ratio-270.34
EPS (TTM)$-0.25
ROE-0.08%
Fundamental Analysis

AI Price Forecasts

1 Month$86.55
3 Months$0.00
1 Year Target$0.00

BLLN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of BillionToOne, Inc. (BLLN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 44.97, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -270.34 and a market capitalization of 3.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-5.53%
5-Day Change
-4.13%
1-Month Change
-0.62%
3-Month Change
-10.72%
6-Month Change
-21.59%
Year-to-Date (YTD) Change
-4.33%
1-Year Change
-21.59%
3-Year Change
-21.59%
5-Year Change
-21.59%
All-Time (Max) Change
-21.59%

Contact Information

https://www.billiontoone.com
(650) 460-2551
1035 O’Brien Drive, Menlo Park, CA, 94025

Company Facts

6,200 Employees
IPO DateNov 6, 2025
CountryUS
Actively Trading

Frequently Asked Questions